The market style continues to switch! The new energy fund track collectively revitalizes, paying close attention to the short-term speculation and taking the lead in breaking through the theme direction.
Track the entire lifecycle of the main sector.
With a compound annual growth rate of only 2.6% over the past five years, China's top 100 pharmaceutical companies are entering an adjustment period. How will the industry break through under internal and external pressures?
According to the data from China Meheco Group, in 2023, multiple operation indicators of the pharmaceutical industry's leading companies have declined. The compound annual growth rate of the top 100 pharmaceutical companies in the country in the past five years is only 2.6%, and the industry as a whole has entered the adjustment phase from the initial high-speed growth. Behind the weak growth, the health industry is also undergoing transformation: overseas licensing trades for innovative drugs have reached a new high, and leading companies are accelerating outward expansion...
Is the chain of pharmacies entering a "mini ice age"? H1 growth rate "downgrades", the industry's high-growth stores may reach turning point.
① The growth rate of sales revenue of all categories in retail pharmacies has slowed down, and the competition in stock continues to intensify. In the first half of this year, it was difficult for major chain pharmacies to increase revenue and profit. ② In the future, the focus of pharmacy competition will shift to commodity extension and services. According to the prediction of Zhongkang Industry Research Institute, the growth rate of pharmaceuticals in all end terminals in 2024 is expected to decrease to 4.9%, a decrease from 2023.
Will you be eliminated if you don't go overseas? In the first half of the year, the proportion of innovative drug outbound business development accounted for about 80% | Industry Dynamics.
①At the 2024 New Investment Conference hosted by Frost Sullivan, the issue of going global was favored by participants. ②There is a new trend in the export of innovative drugs in China, for example, the number of export BDs exceeded License-in for the first time in 2023. ③Some participating experts put forward rational opinions and called for internal strength, not just enthusiasm.
JOYY Analyst Ratings
JOYY Inc (YY) Q2 2024 Earnings Call Transcript Summary
MAU churn, decrease in average revenue per paid user, what does Joyy Group rely on to achieve growth?
Joyy Group released its second quarter financial report for 2024. During the reporting period, Joyy Group achieved revenue of 0.5651 billion USD, a year-on-year growth of 3.3%. During the performance conference call, the group's executives stated that due to the continued strong growth of the advertising business, the BIGO sector is expected to achieve high single-digit revenue growth for the full year.
JOYY's Q2 Global Average Mobile MAUs 275.2M Compared To 275.6M YoY; Total Number Of Paying Users Of BIGO 1.66M, Compared To 1.53M YoY
JOYY Expects Q3 Net Revenues To Be Between $555M-$569M Vs. $575M Consensus
JOYY Beats Top-line and Bottom-line Estimates; Initiates Q3 Outlook
Here's the Major Earnings After the Close Today
JOYY Q2 2024 Earnings Preview
China Stops Releasing Real-time Foreign Fund Flow Data
In July, China's industrial added value above a designated scale increased by 5.1% year-on-year, with manufacturing industry growing by 5.3%.
From a month-on-month perspective, in July, the added value of industries above designated size increased by 0.35% compared with the previous month.
Zai Lab Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Sales Results. Also, the Company Said It Expects Substantial Topline Growth and Path to Achieve Profitability by the End of 2025.
Zai Lab Q2 2024 GAAP Loss Per ADS $(0.82) Misses $(0.70) Estimate, Sales $100.504M Beat $93.136M Estimate
Zai Lab Analyst Ratings
Sustainability Column: How is the Chinese market for geothermal power generation, which Buffett is interested in?
The electric energy hidden underground is becoming a clean resource mine in the eyes of technology giants and conglomerates.
IShares MSCI China Small-Cap ETF Declares Semi-annual Distribution of $0.4843
12 Communication Services Stocks Moving In Wednesday's Pre-Market Session